Type 2 diabetes, prediabetes, insulin resistance, dyslipidemia. The conditions BMI signals — and the conditions GLP-1 medications were originally developed for.
Adults with HbA1c >5.7, family history of T2D, or metabolic syndrome markers (waist circumference, triglycerides, blood pressure). Anyone with BMI ≥27 should screen.
Metabolic health is the longest game in the wellness stack. Sisu doesn't diagnose — your provider does that with lab work. But it does coach the daily inputs (carb timing, fiber, walking after meals, sleep) that move A1C over 90 days. Boring is the strategy.
Sisu doesn't prescribe medications. When this is the right path for you, we route to US-licensed telehealth providers.
💡 Affiliate disclosure: We may earn a commission when you sign up. This doesn't affect what you pay or our recommendations. Sisu routes based on your state, profile, and provider fit — not commission size.
For many people, yes — through sustained weight loss (5–7% of body weight) and increased physical activity. The Diabetes Prevention Program is the most rigorous evidence we have. Sisu coaches the same framework.
No. Sisu helps you screen risk and build habits. Diagnosis requires lab work from a licensed provider — usually HbA1c or fasting glucose. Sisu helps you prepare for and act on those labs.
Both connect to metabolic syndrome. Sisu tracks blood pressure if you log it and flags concerning patterns — but doesn't prescribe or replace your cardiology team.